Search bioRxiv⌕ Search

bioRxiv · 10.1101/413302

Brain age prediction of healthy subjects on anatomic MRI with deep learning: going beyond with an \"explainable AI\" mindset

Abstract

ObjectivesDefine a clinically usable preprocessing pipeline for MRI data\n\nPredict brain age using various machine learning and deep learning algorithms\n\nDefine Caveat against common machine learning traps\n\nData and MethodsWe used 1597 open-access T1 weighted MRI from 24 hospitals.\n\nPreprocessing consisted in applying : N4 bias field correction, registration to MNI152 space, white and grey stripe intensity normalization, skull stripping and brain tissue segmentation\n\nPrediction of brain age was done with growing complexity of data input (histograms, grey matter from segmented MRI, raw data) and models for training (linear models, non linear model such as gradient boosting over decision trees, and 2D and 3D convolutional neural networks).\n\nWork on interpretability consisted in (i) proceeding on basic data visualization like correlations maps between age and voxels value, and generating (ii) weights maps of simpler models, (iii) heatmaps from CNNs model with occlusion method.\n\nResultsProcessing time seemed feasible in a radiological workflow : 5 min for one 3D T1 MRI.\n\nWe found a significant correlation between age and gray matter volume with a correlation r = -0.74. Our best model obtained a mean absolute error of 3.60 years, with fine tuned convolution neural network (CNN) pretrained on ImageNet.\n\nWe carefully analyzed and interpreted the center effect.\n\nOur work on interpretability on simpler models permitted to observe heterogeneity of prediction depending on brain regions known for being involved in ageing (grey matter, ventricles). Occlusion method of CNN showed the importance of Insula and deep grey matter (thalami, caudate nuclei) in predictions.\n\nConclusionsPredicting the brain age using deep learning could be a standardized metric usable in daily neuroradiological reports. An explainable algorithm gives more confidence and acceptability for its use in practice. More clinical studies using this new quantitative biomarker in neurological diseases will show how to use it at its best.\n\nFOREWORDO_ST_ABSAbout OwkinC_ST_ABSOWKIN was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology and Gilles Wainrib, PhD, a pioneer in the field of Artificial Intelligence in biology. OWKIN passed the proof-of-concept phase and is now providing its innovative AI algorithms to several of the largest cancer centers and pharmaceutical companies in Europe and in the US. With offices in New York and Paris, we pride ourselves in building a company culture around transparency, collaboration, challenge, optimism and fun.\n\nOwkins teamOwkins team is international, multidisciplinary with incredible talent in machine learning, medicine and business. Our data scientists are among the best in the world, with several Kaggle Masters (top global 100), a DREAM Challenge top performer, and publications in ICML, NIPS and other top scientific journals.\n\nTasks repartitionIdea : Thomas Clozel, Roger Stup, Simon Jegou, Paul Herent\n\nBibliography : Paul Herent, Simon Jegou, Thomas Clozel\n\nData access : Simon Jegou, Paul Herent\n\nData cleaning : Simon Jegou, Paul Herent\n\nData analysis : Simon Jegou, Paul Herent\n\nData preprocessing : Simon Jegou, Paul Herent\n\nData analysis : Simon Jegou, Paul Herent\n\nTraining of models : Simon Jegou, Paul Herent\n\nWork on interpretability : Simon Jegou, Paul Herent\n\nWriting : Paul Herent\n\nRereading : Simon Jegou, Thomas Clozel, Julien Savatovsky, Roger Stupp, Olivier Elemento, Kim Gillier\n\nSubmission to medical congress : Paul Herent, Simon Jegou\n\nThanks to...\n\nSimon Jegou, for your mentoring in Machine Learning,\n\nThomas Clozel and Gilles Wainrib, for your welcome at Owkin, very benevolent, Roger Stupp, for your support and re-reading,\n\nJulien Savatovsky, for your support and re-reading,\n\nValentin Ame and Sylvain Toldo, for your help on the beautiful figures and the design of the related blogpost,\n\nAll the Owkin team members, for the great team work we did (and hope well do) between Paris and New York : Anna Huyghues Despointes, Anna I. Bondarenko, Pierre Courtiol, Derek T. Russell-Kraft, Cedric Whitney, Meriem Sefta, Vincent Lepage, Adrian Gonzalez, Maxime HE,Paul Jehanno, Raphael Leger, Alicia Simion, Eric Tramel, Mikhail Zaslavskiy, Pierre Manceron, Chloe Simpson, Paul Mabillot, Valentin Ame, Mathieu Galtier, Camille Marini, Sylvain Toldo, Charlie Saillard, Olivier Dehaene, Olivier Moindrot,\n\nPascal Roux, for your support, your help, your advices,\n\nAxelle, for your patience and support.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Herent, P., Jegou, S., Wainrib, G., Clozel, T.. 2018-09-10. Brain age prediction of healthy subjects on anatomic MRI with deep learning: going beyond with an \"explainable AI\" mindset. https://doi.org/10.1101/413302

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Novel Tau Interaction Partners as Potential Biomarkers and Therapeutic Targets in Neurodegenerative Diseases

Alzheimers disease is a progressive neurodegenerative disorder leading to cognitive decline and ultimately death. One of the main hallmarks of this disease is the accumulation of pathological tau protein into neurofibrillary tangles. To better understand these pathological mechanisms, it is essential to characterize the tau protein interactome in health and disease. In this study, we performed a yeast two-hybrid screening using a human brain cDNA library, from which we identified 15 novel tau-interacting proteins that bind to full-length human tau, or its fragments: the N-terminus, microtubule-binding domain, or C-terminus. We subsequently validated these novel interactions using in vitro co-immunoprecipitation and colocalization assays with both physiological and pathological tau isoforms. Furthermore, their interactions with the human tau protein were analyzed using surface plasmon resonance. Finally, an in silico interactome analysis of these newly discovered tau-binding partners revealed several additional interactors that can link them to downstream processes critical to neurodegenerative pathways Our findings offer fresh insights into tau biology and highlight novel targets for therapeutic intervention and biomarker development.

neuroscience↗

Early visual cortex is not functionally necessary for temporal attention: A TMS study

Temporal attention enhances the selective processing of information at a specific point in time and improves perception. Previous neuroimaging studies investigating its neural mechanisms have either conflated temporal attention with temporal expectation or provided correlational evidence. Thus, whether early visual cortex is functionally necessary for temporal attention remains unknown. Here, we combined psychophysics with transcranial magnetic stimulation (TMS) to examine whether V1/V2 are functionally necessary and play a causal role in temporal attention. Observers performed an orientation-discrimination task in which two consecutive stimuli, T1 and T2, were presented in the periphery, preceded by a precue providing either valid or neutral temporal information. Double-pulse TMS was delivered under four conditions: at T1 (T1-TMS), at T2 (T2-TMS), at both T1 and T2 (both-TMS), or not at all (none-TMS), to assess its effects on temporal attention and the efficacy of the stimulation was verified by pupil size analysis. Behavioral results revealed robust temporal attention benefits on d', reaction time, and the Balanced Integration Score (BIS) across all four TMS conditions, indicating that the benefits of temporal attention were unaffected by occipital TMS. Furthermore, pupil dilation was largest in the both-TMS condition, followed by the T1-TMS and T2-TMS conditions, and smallest in the none-TMS condition, providing physiological verification of the stimulation protocol. Together, these findings reveal the first causal evidence that the early visual cortex is not functionally necessary for endogenous temporal attention.

neuroscience↗

Disentanglement of persistent and dynamic neural substrates of working memory

Competing theories of working memory have alternatively emphasized the importance of persistent and dynamic substrates of this cognitive function. Here, we directly tested these theories by computationally isolating the contributions of persistent and dynamic activity to working memory. We analyzed neuronal population activity recordings in macaques doing match/non-match working memory tasks. We first extracted signatures of persistent and dynamic activity through cue-specific temporal means, temporal principal components, and correlations of activity patterns across task epochs. We then generated synthetic data constrained by these signatures, and decoded cue stimuli from these data, separately from persistent and non-persistent neurons. We found that high decoding performance arose from a nuanced interplay of persistent and dynamic activity. Specifically, we could decode stimuli at empirical or above-chance levels across all tasks only from persistent neurons, but only after constraining correlations of activity patterns across epochs. In this way, we showed distinct roles for persistent and dynamic neuronal activity that help to unify two competing theories of working memory. More broadly, we also advanced computational controlled experiments as a principled framework for adjudicating between competing models of neuronal population activity.

neuroscience↗